683242-75-3 Usage
Explanation
The molecular formula represents the number of atoms of each element present in a molecule of the compound.
Explanation
The compound is derived from the parent compound 2-chloro-1H-benzimidazole-5-carboxylic acid by replacing the carboxylic acid group with a methyl ester group.
Explanation
These functional groups are responsible for the compound's reactivity and its potential biological activities.
Explanation
The compound is used as an intermediate in the synthesis of different pharmaceutical drugs, particularly anti-inflammatory agents and other bioactive compounds.
Explanation
The benzimidazole ring is known to have various biological activities, which can be exploited for therapeutic purposes.
Explanation
The presence of the methyl ester group makes the compound more stable and easier to work with in chemical reactions, compared to the parent carboxylic acid.
Explanation
The compound's structure and functional groups, particularly the benzimidazole ring, contribute to its potential therapeutic properties, making it a valuable building block for drug development.
Explanation
The compound is soluble in organic solvents, which is important for its use in chemical reactions and pharmaceutical formulations.
Explanation
The compound is stable under typical laboratory conditions, making it suitable for use in research and development.
Explanation
As with many chemicals, 1H-Benzimidazole-5-carboxylic acid, 2-chloro-, methyl ester can pose health risks if not handled properly. It is important to follow safety guidelines and use appropriate personal protective equipment when working with this compound.
Structure
Methyl ester derivative of 2-chloro-1H-benzimidazole-5-carboxylic acid
Functional groups
Benzimidazole ring, chloro group, methyl ester group, and carboxylic acid group
Pharmaceutical applications
Building block for the synthesis of various pharmaceutical agents
Biological activities
Exhibits a range of biological activities due to the benzimidazole ring
Esterification
Methyl ester form allows for easier handling and manipulation in chemical reactions
Potential therapeutic properties
Possesses potential therapeutic properties due to its structure and functional groups
Solubility
Soluble in organic solvents such as ethanol, methanol, and dimethyl sulfoxide (DMSO)
Stability
Stable under normal laboratory conditions
Hazards
Potential irritant and harmful if swallowed or inhaled
Check Digit Verification of cas no
The CAS Registry Mumber 683242-75-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,8,3,2,4 and 2 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 683242-75:
(8*6)+(7*8)+(6*3)+(5*2)+(4*4)+(3*2)+(2*7)+(1*5)=173
173 % 10 = 3
So 683242-75-3 is a valid CAS Registry Number.
683242-75-3Relevant articles and documents
GLP-1R AGONISTS AND USES THEREOF
-
Page/Page column 59; 119; 120, (2020/10/21)
Provided herein are compounds of Formula (I) and pharmaceutical compositions thereof, for use in, e.g. treating type 2 diabetes mellitus, pre-diabetes, obesity, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and cardiovascular disease.
COMPOUNDS AS RAS INHIBITORS AND USE THEREOF
-
, (2019/04/11)
A compound of Formula (Ia) or (Ib), or a pharmaceutically acceptable salt thereof is described, wherein the substituents are as defined herein. Pharmaceutical compositions comprising the same and method of using the same are also described.
BICYCLIC HYDROXAMIC ACIDS USEFUL AS INHIBITORS OF MAMMALIAN HISTONE DEACETYLASE ACTIVITY
-
Page/Page column 80, (2017/07/14)
A compound of formula (Ia) or (Ib) or a pharmaceutically acceptable salt thereof. The compound is an inhibitor of a histone deacetylase, and as such is useful in terepy, e.g. in the treatment of autoimmune disorders, mental disorders, neurodegenerative disorders, and hyperproliferative disorders.
